GT
CTVA icon

Glenmede Trust’s Corteva CTVA Stock Holding History

Glenmede Trust’s Portfolio CTVA Stock Details CTVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.4M Sell
264,180
-323
-0.1% -$25.9K 0.1% 171
2026
Q1 		$22.1M Sell
264,503
-619
-0.2% -$46.6K 0.11% 164
2025
Q4 		$17.8M Buy
+265,122
New +$17.1M 0.08% 203
2025
Q1 		$15.5M Sell
245,755
-4,114
-2% -$254K 0.08% 235
2024
Q4 		$14.2M Sell
249,869
-8,627
-3% -$510K 0.07% 285
2024
Q3 		$15.2M Sell
258,496
-2,884
-1% -$157K 0.07% 281
2024
Q2 		$14.1M Sell
261,380
-537
-0.2% -$29.6K 0.07% 284
2024
Q1 		$15.1M Buy
261,917
+988
+0.4% +$51K 0.08% 279
2023
Q4 		$12.5M Sell
260,929
-132,491
-34% -$6.32M 0.06% 313
2023
Q3 		$20.1M Buy
393,420
+6,189
+2% +$328K 0.12% 188
2023
Q2 		$23.4M Buy
387,231
+32
+0% +$1.87K 0.13% 170
2023
Q1 		$23.4M Sell
387,199
-230,872
-37% -$14.1M 0.13% 170
2022
Q4 		$36.3M Buy
618,071
+17,605
+3% +$1.11M 0.21% 110
2022
Q3 		$34.3M Sell
600,466
-23,841
-4% -$1.39M 0.22% 115
2022
Q2 		$33.8M Sell
624,307
-40,056
-6% -$2.33M 0.2% 117
2022
Q1 		$38.2M Sell
664,363
-26,335
-4% -$1.35M 0.19% 127
2021
Q4 		$32.7M Buy
690,698
+246,317
+55% +$11.2M 0.16% 152
2021
Q3 		$18.7M Sell
444,381
-15,260
-3% -$660K 0.1% 242
2021
Q2 		$20.4M Sell
459,641
-46,223
-9% -$2.14M 0.11% 221
2021
Q1 		$23.6M Sell
505,864
-19,181
-4% -$849K 0.13% 185
2020
Q4 		$20.3M Buy
525,045
+16,339
+3% +$584K 0.11% 217
2020
Q3 		$14.7M Sell
508,706
-517,003
-50% -$14.6M 0.09% 249
2020
Q2 		$27.5M Buy
1,025,709
+459,435
+81% +$12M 0.17% 139
2020
Q1 		$16.7M Hold
566,274
– – 0.08% 301
2019
Q4 		$16.7M Sell
566,274
-1,097,330
-66% -$29.1M 0.08% 301
2019
Q3 		$46.6M Buy
1,663,604
+1,066,526
+179% +$30.8M 0.21% 125
2019
Q2 		$17.7M Buy
+597,078
New +$16.1M 0.08% 320

Other funds holding CTVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Glenmede Trust's CTVA Position: Q2 2026 in Review

Glenmede Trust reduced its Corteva (CTVA) stake by 0.12% in Q2 2026, selling an estimated $25.9K and leaving 264,180 shares worth $22.4M. The position accounts for 0.1% of the portfolio, ranked #171.

Glenmede Trust first reported a position in CTVA in Q2 2019 and has held it in 27 quarters since. The position peaked at $46.6M in Q3 2019. 1,491 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Glenmede Trust held 264,180 shares of Corteva worth $22.4M as of Q2 2026.
  • Glenmede Trust sold 323 Corteva shares in Q2 2026, an estimated $25.9K.
  • Corteva made up 0.1% of Glenmede Trust's portfolio in Q2 2026, its #171 holding.
  • Glenmede Trust first reported a position in Corteva in Q2 2019 and has held it in 27 quarters since.
  • Glenmede Trust's Corteva position peaked at $46.6M in Q3 2019.
  • 1,491 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.